Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesEMA accepts Mylan, Biocon Trastuzumab biosimilar for review

SHOW NAMES

Trending Topics

Sensex Live Texmaco Rail Share Price John Cockerill India Shares GK Energy IPO Opens Today iValue Infosolutions IPO Day 2

business

EMA accepts Mylan, Biocon Trastuzumab biosimilar for review

This is the second biosimilar submission developed by the partnership that has been accepted for review in Europe, global pharma major Mylan and Biocon said in a statement today.

first published: Aug 25, 2016 08:46 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347